The content is available as a PDF (173.5 KB).
Footnotes
The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contribution represent exclusively the personal opinion of the authors
References
- Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowtz RS, Leavitt T, Griffiths, T, Parker, L, Zurawski VR Jr, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887 [DOI] [PubMed] [Google Scholar]
- Berek JS, Knapp RC, Malkasian GD, Lavin, PT, Whitney C, Niloff JM, Bast RC (1986) CA 125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol 67:685–689 [DOI] [PubMed] [Google Scholar]
- Cohen AM, Shank B, Friedman MA (1989) Colorectal cancer: In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology; J. B. Lippincott Company (3rd edn):895–964
- Lange PH, McIntire R, Waldmann TA, Hakala TR, Fraley EE (1976) Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. N Engl J Med 295:1237–1240 [DOI] [PubMed] [Google Scholar]